Duality Biologics Announces License Agreement of its Next-generation ADC platform with Adcendo ...Middle East

Duality to grant license of DITAC (Duality Immune Toxin Antibody Conjugates) platform to Adcendo for its lead uPARAP ADC program Duality to receive upfront payment, development, regulatory and commercial milestones, and tiered royalties Collaboration based on synergies between Adcendo and...

Hence then, the article about duality biologics announces license agreement of its next generation adc platform with adcendo was published today ( Thursday 05/01/2023 - 04:16 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Duality Biologics Announces License Agreement of its Next-generation ADC platform with Adcendo )

Also on site :

• Human heads displayed at Ecuador tourist beach in warning to gangs
• Nazi salutes and drug cartels: Dutch mercenary recounts service with Kiev’s military
• Macy’s Valley Fair shoppers thwart Rolex watch thieves